M2S and the Vascular Quality Initiative® adds first venous procedure module – Inferior Vena Cava Filter – to its PATHWAYS database
West Lebanon, NH – February 15, 2013: M2S, the exclusive technology provider for the Vascular Quality Initiative® (VQI®), announces the release of Inferior Vena Cava (IVC) Filter procedure module to its PATHWAYS clinical data performance platform. IVC Filter is the first venous module added to the database, expanding the VQI to become the comprehensive arterial and venous registry.
With the release of IVC Filter, the VQI now monitors eleven vascular procedures through M2S’s PATHWAYS platform. In January, the VQI announced its collaboration with the American Venous Forum (AVF) to add venous interventions. This growth increases the value of benchmarking among participants and regional quality groups, and expands the scope for quality improvement and quality research projects that affect patient care. Today the VQI has more than 220 participating centers across the United States and Canada that have entered over 75,000 procedures into the PATHWAYS database.
M2S’s PATHWAYS platform provides participating centers and providers with real-time data collection and reporting tools, empowering users to collaborate on outcomes and implement quality improvement projects to impact quality and cost of vascular care. M2S, along with the AVF and Society for Vascular Surgery, plans to expand the database with additional venous procedure modules, including Venous Stenting, DVT Thrombolysis, and Upper Extremity DVT treatment.
M2S is a healthcare performance management solutions company that provides innovative technology and services for the healthcare industry to manage clinical information and utilize that information to improve the quality of patient care and reduce costs. The Vascular Quality Initiative is built on M2S’s PATHWAYS clinical data performance platform, allowing users to track, measure, and analyze clinical information, promote collaboration, objectively drive decisions, and optimize performance. For more information, visit www.m2s.com.